DMXAA

Manufacturer	TargetMol
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Amount	5mg
Item no.	TMO-T6273-5mg
CASRN	117570-53-3
eClass 6.1	32169090
eClass 9.0	32169090
Available
Short Description	Vadimezan (NSC 640488) is a fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan(NSC 640488) induces the cytokines tumor necrosis alpha (TNF-alpha), serotonin and nitric oxide, resulting in hemorrhagic necrosis and a decrease in angiogenesis. This agent also stimulates the anti-tumor activity of tumor-associated macrophages.
Shipping	cool pack
Storage	-20°
Target names or alias	ASA-404 , NSC 640488 , 5, 6-Dimethylxanthenone-4-acetic Acid , DMXAA
Molecular Weight	282, 29
Pathway	Immunology/Inflammation\|\|\|Angiogenesis\|\|\|Microbiology/Virology
Target	IFNAR\|\|\|STING\|\|\|Influenza Virus\|\|\|VDA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5mg

available

Delivery expected until 6/6/2024